BSE Live
Oct 10, 16:01Prev. Close
996.05
Open Price
996.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:58Prev. Close
994.45
Open Price
997.90
Bid Price (Qty.)
993.45 (355)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Zydus Lifesciences (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 37.03 | 22.22 | 20.51 | 18.61 | 24.27 | |
Diluted EPS (Rs.) | 37.03 | 22.22 | 20.51 | 18.61 | 24.27 | |
Cash EPS (Rs.) | 48.20 | 31.03 | 28.52 | 25.74 | 35.48 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 119.05 | 86.22 | 83.44 | 68.39 | 109.08 | |
Book Value [InclRevalReserve]/Share (Rs.) | 119.05 | 86.22 | 83.44 | 68.39 | 109.08 | |
Revenue from Operations/Share (Rs.) | 265.90 | 213.15 | 183.61 | 145.07 | 218.03 | |
PBDIT/Share (Rs.) | 58.47 | 42.65 | 37.15 | 30.43 | 42.17 | |
PBIT/Share (Rs.) | 49.05 | 34.46 | 29.43 | 23.88 | 30.97 | |
PBT/Share (Rs.) | 43.90 | 28.17 | 25.75 | 21.81 | 28.14 | |
Net Profit/Share (Rs.) | 38.78 | 22.83 | 20.80 | 19.19 | 24.28 | |
NP After MI And SOA / Share (Rs.) | 37.03 | 22.22 | 20.51 | 18.61 | 24.27 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 21.98 | 20.01 | 20.23 | 20.97 | 19.33 | |
PBIT Margin (%) | 18.44 | 16.16 | 16.03 | 16.45 | 14.20 | |
PBT Margin (%) | 16.50 | 13.21 | 14.02 | 15.03 | 12.90 | |
Net Profit Margin (%) | 14.58 | 10.71 | 11.33 | 13.22 | 11.13 | |
NP After MI And SOA Margin (%) | 13.92 | 10.42 | 11.17 | 12.83 | 11.13 | |
Return on Networth/Equity (%) | 31.87 | 26.28 | 25.04 | 27.67 | 22.27 | |
Return on Capital Employed (%) | 18.72 | 13.36 | 14.61 | 17.70 | 13.36 | |
Return on Assets (%) | 13.36 | 9.07 | 10.02 | 11.62 | 9.68 | |
Total Debt/Equity (X) | 0.67 | 1.06 | 0.80 | 0.53 | 0.64 | |
Asset Turnover Ratio (%) | 95.96 | 87.05 | 89.73 | 90.59 | 87.04 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.54 | 1.39 | 1.33 | 1.30 | 1.37 | |
Quick Ratio (X) | 0.89 | 0.84 | 0.76 | 0.77 | 0.83 | |
Inventory Turnover Ratio (X) | 5.13 | 4.97 | 5.02 | 4.90 | 5.86 | |
Dividend Payout Ratio (NP) (%) | 20.27 | 20.25 | 21.93 | 21.64 | 24.73 | |
Dividend Payout Ratio (CP) (%) | 16.16 | 14.79 | 15.93 | 16.00 | 16.92 | |
Earnings Retention Ratio (%) | 79.73 | 79.75 | 78.07 | 78.36 | 75.27 | |
Cash Earnings Retention Ratio (%) | 83.84 | 85.21 | 84.07 | 84.00 | 83.08 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 9.53 | 5.48 | 7.98 | 11.53 | 10.93 | |
Interest Coverage Ratios (Post Tax) (%) | 9.53 | 5.48 | 7.98 | 11.53 | 10.93 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 12,137.40 | 4,741.44 | 3,966.00 | 4,609.88 | 4,659.21 | |
EV/Net Operating Revenue (X) | 3.35 | 1.63 | 1.72 | 2.53 | 3.40 | |
EV/EBITDA (X) | 15.22 | 8.15 | 8.50 | 12.06 | 17.60 | |
MarketCap/Net Operating Revenue (X) | 3.10 | 1.28 | 1.39 | 2.31 | 3.10 | |
Retention Ratios (%) | 79.72 | 79.74 | 78.06 | 78.35 | 75.26 | |
Price/BV (X) | 7.10 | 3.22 | 3.11 | 4.99 | 6.20 | |
Price/Net Operating Revenue | 3.10 | 1.28 | 1.39 | 2.31 | 3.10 | |
Earnings Yield | 0.04 | 0.08 | 0.08 | 0.06 | 0.04 |
07.10.2025
19.09.2025
16.09.2025
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
24.06.2025
Zydus Life Consolidated March 2025 Net Sales at Rs 6,527.90 crore, up 17.96% Y-o-Y
21.05.2025
Zydus Life Standalone March 2025 Net Sales at Rs 5,819.60 crore, up 74.64% Y-o-Y
05.02.2025
Zydus Life Standalone December 2024 Net Sales at Rs 2,515.90 crore, up 6.1% Y-o-Y
12.07.2023
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
08.07.2022
Zydus Lifesciences Q1 PAT may dip 10.6% YoY to Rs 505.2 cr: Prabhudas Lilladher
13.01.2022
Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher
06.10.2021
Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher